Stay updated on Nab-sirolimus in Severe PAH Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.

Latest updates to the Nab-sirolimus in Severe PAH Clinical Trial page
- Check2 days agoChange DetectedThe study record’s revision stamp changed from v3.6.3 to v3.6.4. This appears to be a minor administrative update to the entry and does not alter the study details, eligibility criteria, or user-facing content.SummaryDifference0.2%

- Check9 days agoChange DetectedNo additions or deletions were provided, so there are no textual changes to report. The page content remains as described by the input.SummaryDifference0.1%

- Check17 days agoChange DetectedNo textual changes were provided for the page. The study record content appears unchanged across sections such as the Brief Summary, Eligibility Criteria, and Study Plan.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a newer version of the page.SummaryDifference0.1%

- Check31 days agoChange DetectedFooter revision tag updated from v3.6.0 to v3.6.2, indicating a minor update to the page's version and related content.SummaryDifference0.1%

- Check45 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and the navigation now includes new sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment heading replaces the old Intervention / Treatment. The revision tag at the bottom was updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Nab-sirolimus in Severe PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.